Media Summary: Brian Longstreet is the Chief Operating Officer at CorriXR Therapeutics, a pioneering biotechnology company. Join us as we ... Nobody told you this about your immunotherapy infusion. The data will surprise you.  ... Theranostics is a groundbreaking topic that's reshaping how we diagnose and treat

Eueic Podcast Series Episode 7 Fighting Cancer With Cell And Gene Therapy - Detailed Analysis & Overview

Brian Longstreet is the Chief Operating Officer at CorriXR Therapeutics, a pioneering biotechnology company. Join us as we ... Nobody told you this about your immunotherapy infusion. The data will surprise you.  ... Theranostics is a groundbreaking topic that's reshaping how we diagnose and treat Sweden's fastest growing private biotech, Anocca, is making plans for clinical trials in pancreatic This week's speakers in the Demystifying Medicine

Photo Gallery

#EUeic Podcast Series - Episode 7: Fighting cancer with Cell and Gene therapy
Engineering Off-the-Shelf Cell Therapies for Cancer & Autoimmune Disease
Is gene therapy THE FUTURE OF CANCER TREATMENT? | Brian Longstreet
30+ Years in Immunology and This Immunotherapy & Keytruda Finding Still Caught Me Off Guard
Better Than CAR T-Cell Therapy: NEW CANCER Treatment Is Now Here!
Theranostics: A New Weapon Against Cancer - Part 2
Cell and Gene Therapy: Revolutionizing Cancer Treatment
Anocca’s VIDAR-1: Revolutionizing pancreatic cancer with TCR-T cell therapy
Demystifying Medicine—When Immunity Fights Back: Harnessing Rejection to Defeat Cancer
Sponsored
Sponsored
View Detailed Profile
#EUeic Podcast Series - Episode 7: Fighting cancer with Cell and Gene therapy

#EUeic Podcast Series - Episode 7: Fighting cancer with Cell and Gene therapy

In this

Engineering Off-the-Shelf Cell Therapies for Cancer & Autoimmune Disease

Engineering Off-the-Shelf Cell Therapies for Cancer & Autoimmune Disease

On this

Sponsored
Is gene therapy THE FUTURE OF CANCER TREATMENT? | Brian Longstreet

Is gene therapy THE FUTURE OF CANCER TREATMENT? | Brian Longstreet

Brian Longstreet is the Chief Operating Officer at CorriXR Therapeutics, a pioneering biotechnology company. Join us as we ...

30+ Years in Immunology and This Immunotherapy & Keytruda Finding Still Caught Me Off Guard

30+ Years in Immunology and This Immunotherapy & Keytruda Finding Still Caught Me Off Guard

Nobody told you this about your immunotherapy infusion. The data will surprise you. #keytruda #immunotherapy ...

Better Than CAR T-Cell Therapy: NEW CANCER Treatment Is Now Here!

Better Than CAR T-Cell Therapy: NEW CANCER Treatment Is Now Here!

A new

Sponsored
Theranostics: A New Weapon Against Cancer - Part 2

Theranostics: A New Weapon Against Cancer - Part 2

Theranostics is a groundbreaking topic that's reshaping how we diagnose and treat

Cell and Gene Therapy: Revolutionizing Cancer Treatment

Cell and Gene Therapy: Revolutionizing Cancer Treatment

In this first

Anocca’s VIDAR-1: Revolutionizing pancreatic cancer with TCR-T cell therapy

Anocca’s VIDAR-1: Revolutionizing pancreatic cancer with TCR-T cell therapy

Sweden's fastest growing private biotech, Anocca, is making plans for clinical trials in pancreatic

Demystifying Medicine—When Immunity Fights Back: Harnessing Rejection to Defeat Cancer

Demystifying Medicine—When Immunity Fights Back: Harnessing Rejection to Defeat Cancer

This week's speakers in the Demystifying Medicine